Activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in major depressive disorder with or without metabolic syndrome. 2017

Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
Mostar Center for Mental Health, Mostar Health Center, Hrvatskih branitelja bb, 88 000 Mostar, Bosnia and Herzegovina, marko.martinac@tel.net.ba.

BACKGROUND The aim of the present study was to explore the differences in serum CRP, IL-6, TNF-α, ACTH and cortisol among patients with major depressive disorder with or without metabolic syndrome (MS) compared to a healthy control group. METHODS The MDD study group consisted of 80 patients (mean age of 50.03±9.55 years). The control group was recruited from the hospital personnel and it consisted of 40 examinees (mean age of 47.20±7.99 years). All patients who participated in the study were diagnosed with depressive disorder using MINI questionnaire, and Hamilton rating scale for depression. Diagnosis of the metabolic syndrome was set by NCEP ATP III criteria. RESULTS Examinees with depression but without MS had significantly more cortisol concentration when compared to the control group. CRP was significantly higher in the MDD group when compared to the control group and in MDD+MS group when compared to the control group. IL6 serum levels were significantly higher in the MDD group when compared to the healthy control group, and in MDD+MS group when compared to the healthy control group. ACTH had significant independent predictive values for abdominal obesity. Levels of TNF-α were statistically significant independent predictors for hyperglycaemia. Statistically significant predictive values for MDD were found for cortisol, and IL-6. CONCLUSIONS Results shown here emphasise the importance of neuroendocrine and inflammatory factors in pathogenesis of depressive disorder and MS. Further prospective research is necessary to clarify possible causal relationship between depression and MS. It is necessary to investigate the possibility of a joint biological mechanism in pathogenesis of these two disorders with the special attention given to the disturbances in the immune system.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic

Related Publications

Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
February 1989, Psychiatry research,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
January 2015, Psychoneuroendocrinology,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
October 2017, International journal of molecular sciences,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
October 1987, Psychiatry research,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
May 2006, Psychiatry research,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
January 2003, Turk psikiyatri dergisi = Turkish journal of psychiatry,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
June 2009, Archives of general psychiatry,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
August 2012, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
November 2006, Annals of the New York Academy of Sciences,
Marko Martinac, and Dragan Babić, and Milenko Bevanda, and Ivan Vasilj, and Danijela Bevanda Glibo, and Dalibor Karlović, and Miro Jakovljević
April 2017, Metabolic brain disease,
Copied contents to your clipboard!